<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xmlns="ted/R2.0.9.S02/publication"
            xmlns:n2016="ted/2016/nuts"
            xsi:schemaLocation="ted/R2.0.9.S02/publication TED_EXPORT.xsd"
            VERSION="R2.0.9.S02.E01"
            DOC_ID="001593-2018"
            EDITION="2018002">
   <TECHNICAL_SECTION>
      <RECEPTION_ID>18-000615-001</RECEPTION_ID>
      <DELETION_DATE>20180412</DELETION_DATE>
      <FORM_LG_LIST>SK </FORM_LG_LIST>
      <COMMENTS>From Convertor</COMMENTS>
   </TECHNICAL_SECTION>
   <LINKS_SECTION>
      <XML_SCHEMA_DEFINITION_LINK xlink:type="simple"
                                  xlink:href="http://ted.europa.eu"
                                  xlink:title="TED WEBSITE"/>
      <OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
   </LINKS_SECTION>
   <CODED_DATA_SECTION>
      <REF_OJS>
         <COLL_OJ>S</COLL_OJ>
         <NO_OJ>2</NO_OJ>
         <DATE_PUB>20180104</DATE_PUB>
      </REF_OJS>
      <NOTICE_DATA>
         <NO_DOC_OJS>2018/S 002-001593</NO_DOC_OJS>
         <URI_LIST>
            <URI_DOC LG="SK">http://ted.europa.eu/udl?uri=TED:NOTICE:001593-2018:TEXT:SK:HTML</URI_DOC>
         </URI_LIST>
         <LG_ORIG>SK</LG_ORIG>
         <ISO_COUNTRY VALUE="SK"/>
         <IA_URL_GENERAL>http://www.vszp.sk</IA_URL_GENERAL>
         <ORIGINAL_CPV CODE="33652000">Antineoplastic and immunomodulating agents</ORIGINAL_CPV>
         <n2016:PERFORMANCE_NUTS CODE="SK0">SLOVENSKO</n2016:PERFORMANCE_NUTS>
         <n2016:CA_CE_NUTS CODE="SK0">SLOVENSKO</n2016:CA_CE_NUTS>
         <n2016:TENDERER_NUTS CODE="SK">SLOVENSKO</n2016:TENDERER_NUTS>
         <VALUES>
            <VALUE TYPE="PROCUREMENT_TOTAL" CURRENCY="EUR">11958068.00</VALUE>
         </VALUES>
         <REF_NOTICE>
            <NO_DOC_OJS>2017/S 170-348366</NO_DOC_OJS>
         </REF_NOTICE>
      </NOTICE_DATA>
      <CODIF_DATA>
         <DS_DATE_DISPATCH>20180102</DS_DATE_DISPATCH>
         <AA_AUTHORITY_TYPE CODE="6">Body governed by public law</AA_AUTHORITY_TYPE>
         <TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE>
         <NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE>
         <PR_PROC CODE="1">Open procedure</PR_PROC>
         <RP_REGULATION CODE="5">European Union, with participation by GPA countries</RP_REGULATION>
         <TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID>
         <AC_AWARD_CRIT CODE="1">Lowest price</AC_AWARD_CRIT>
         <MA_MAIN_ACTIVITIES CODE="8">Other</MA_MAIN_ACTIVITIES>
         <HEADING>01B03</HEADING>
         <INITIATOR>01</INITIATOR>
         <DIRECTIVE VALUE="2014/24/EU"/>
      </CODIF_DATA>
   </CODED_DATA_SECTION>
   <TRANSLATION_SECTION>
      <ML_TITLES>
         <ML_TI_DOC LG="BG">
            <TI_CY>Cлoвaшкo</TI_CY>
            <TI_TOWN>Bratislava</TI_TOWN>
            <TI_TEXT>
               <P>Антинеопластични средства и имуномодулатори</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="CS">
            <TI_CY>Slovensko</TI_CY>
            <TI_TOWN>Bratislava</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplastika a imunomodulátory</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DA">
            <TI_CY>Slovakiet</TI_CY>
            <TI_TOWN>Bratislava</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplastiske og immunmodulerende midler</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DE">
            <TI_CY>die Slowakei</TI_CY>
            <TI_TOWN>Bratislava</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplastische und immunmodulierende Mittel</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EL">
            <TI_CY>Σλοβακία</TI_CY>
            <TI_TOWN>Μπρατισλάβα</TI_TOWN>
            <TI_TEXT>
               <P>Αντινεοπλασματικά και ανοσορρυθμιστικά φάρμακα</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EN">
            <TI_CY>Slovakia</TI_CY>
            <TI_TOWN>Bratislava</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplastic and immunomodulating agents</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ES">
            <TI_CY>Eslovaquia</TI_CY>
            <TI_TOWN>Bratislava</TI_TOWN>
            <TI_TEXT>
               <P>Agentes antineoplásicos e inmunomoduladores</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ET">
            <TI_CY>Slovakkia</TI_CY>
            <TI_TOWN>Bratislava</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplastilised ja immuunmoduleerivad ained</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FI">
            <TI_CY>Slovakia</TI_CY>
            <TI_TOWN>Bratislava</TI_TOWN>
            <TI_TEXT>
               <P>Solunsalpaajat ja sytostaatit sekä immunomodulantit</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FR">
            <TI_CY>Slovaquie</TI_CY>
            <TI_TOWN>Bratislava</TI_TOWN>
            <TI_TEXT>
               <P>Antinéoplasiques et immunomodulateurs</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="GA">
            <TI_CY>Slóvaic, an t</TI_CY>
            <TI_TOWN>Bratislava</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplastic and immunomodulating agents</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HR">
            <TI_CY>Slovačka</TI_CY>
            <TI_TOWN>Bratislava</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplastični lijekovi i imunomodulatori</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HU">
            <TI_CY>Szlovákia</TI_CY>
            <TI_TOWN>Bratislava</TI_TOWN>
            <TI_TEXT>
               <P>Daganatellenes és immunmodulátor szerek</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="IT">
            <TI_CY>Slovacchia</TI_CY>
            <TI_TOWN>Bratislava</TI_TOWN>
            <TI_TEXT>
               <P>Agenti antineoplastici e immunomodulatori</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LT">
            <TI_CY>Slovakija</TI_CY>
            <TI_TOWN>Bratislava</TI_TOWN>
            <TI_TEXT>
               <P>Antinavikiniai vaistai ir imunomoduliatoriai</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LV">
            <TI_CY>Slovākija</TI_CY>
            <TI_TOWN>Bratislava</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplastiskie līdzekļi un imūnmodulatori</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="MT">
            <TI_CY>is-Slovakkja</TI_CY>
            <TI_TOWN>Bratislava</TI_TOWN>
            <TI_TEXT>
               <P>Aġenti ta' l-antineoplastika u ta' l-immunomodulaturi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="NL">
            <TI_CY>Slowakije</TI_CY>
            <TI_TOWN>Bratislava</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplastische en immunomodulerende middelen</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PL">
            <TI_CY>Słowacja</TI_CY>
            <TI_TOWN>Bratysława</TI_TOWN>
            <TI_TEXT>
               <P>Środki przeciwnowotworowe i immunomodulacyjne</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PT">
            <TI_CY>Eslováquia</TI_CY>
            <TI_TOWN>Bratislava</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplásicos e imunomoduladores</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="RO">
            <TI_CY>Slovacia</TI_CY>
            <TI_TOWN>Bratislava</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplazice şi imunomodulatoare</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SK">
            <TI_CY>Slovensko</TI_CY>
            <TI_TOWN>Bratislava</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplastické a imunomodulačné činidlá</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SL">
            <TI_CY>Slovaška</TI_CY>
            <TI_TOWN>Bratislava</TI_TOWN>
            <TI_TEXT>
               <P>Zdravila z delovanjem na novotvorbe in imunomodulatorji</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SV">
            <TI_CY>Slovakien</TI_CY>
            <TI_TOWN>Bratislava</TI_TOWN>
            <TI_TEXT>
               <P>Cytostatika/cytotoxiska medel och immunmodulerande medel</P>
            </TI_TEXT>
         </ML_TI_DOC>
      </ML_TITLES>
      <ML_AA_NAMES>
         <AA_NAME LG="SK">Všeobecná zdravotná poisťovňa, a.s.</AA_NAME>
      </ML_AA_NAMES>
   </TRANSLATION_SECTION>
   <FORM_SECTION>
      <F03_2014 CATEGORY="ORIGINAL" FORM="F03" LG="SK">
         <CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY>
               <OFFICIALNAME>Všeobecná zdravotná poisťovňa, a.s.</OFFICIALNAME>
               <NATIONALID>35937874</NATIONALID>
               <ADDRESS>Panónska cesta 2</ADDRESS>
               <TOWN>Bratislava - Petržalka</TOWN>
               <POSTAL_CODE>85104</POSTAL_CODE>
               <COUNTRY VALUE="SK"/>
               <CONTACT_POINT>Ing. Jana Hosová</CONTACT_POINT>
               <PHONE>+421 220824515</PHONE>
               <E_MAIL>jana.hosova@vszp.sk</E_MAIL>
               <n2016:NUTS CODE="SK0"/>
               <URL_GENERAL>http://www.vszp.sk</URL_GENERAL>
               <URL_BUYER>http://www.uvo.gov.sk</URL_BUYER>
            </ADDRESS_CONTRACTING_BODY>
            <CA_TYPE VALUE="BODY_PUBLIC"/>
            <CA_ACTIVITY_OTHER>zdravotné poistenie</CA_ACTIVITY_OTHER>
         </CONTRACTING_BODY>
         <OBJECT_CONTRACT>
            <TITLE>
               <P>Lieky ATC skupiny L04AA27</P>
            </TITLE>
            <REFERENCE_NUMBER>25/2017/JH</REFERENCE_NUMBER>
            <CPV_MAIN>
               <CPV_CODE CODE="33652000"/>
            </CPV_MAIN>
            <TYPE_CONTRACT CTYPE="SUPPLIES"/>
            <SHORT_DESCR>
               <P>Lieky ATC skupiny L04AA27.</P>
            </SHORT_DESCR>
            <VAL_TOTAL CURRENCY="EUR">11958068.00</VAL_TOTAL>
            <NO_LOT_DIVISION/>
            <OBJECT_DESCR ITEM="1">
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33652000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="SK0"/>
               <MAIN_SITE>
                  <P>Slovenská republika.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>9 200 balení lieku na obdobie 2 rokov.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
         </OBJECT_CONTRACT>
         <PROCEDURE>
            <PT_OPEN/>
            <FRAMEWORK/>
            <EAUCTION_USED/>
            <CONTRACT_COVERED_GPA/>
            <NOTICE_NUMBER_OJ>2017/S 170-348366</NOTICE_NUMBER_OJ>
            <TERMINATION_PIN/>
         </PROCEDURE>
         <AWARD_CONTRACT ITEM="1">
            <TITLE>
               <P>Rámcová dohoda č. 440/2017</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-20</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>6</NB_TENDERS_RECEIVED>
               <NB_TENDERS_RECEIVED_SME>0</NB_TENDERS_RECEIVED_SME>
               <NB_TENDERS_RECEIVED_OTHER_EU>0</NB_TENDERS_RECEIVED_OTHER_EU>
               <NB_TENDERS_RECEIVED_NON_EU>0</NB_TENDERS_RECEIVED_NON_EU>
               <NB_TENDERS_RECEIVED_EMEANS>0</NB_TENDERS_RECEIVED_EMEANS>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Unipharma - 1. slovenská lekárnická akciová spoločnosť</OFFICIALNAME>
                     <NATIONALID>31625657</NATIONALID>
                     <ADDRESS>Opatovská cesta 4</ADDRESS>
                     <TOWN>Bojnice</TOWN>
                     <POSTAL_CODE>97201</POSTAL_CODE>
                     <COUNTRY VALUE="SK"/>
                     <E_MAIL>unipharma@unipharma.sk</E_MAIL>
                     <n2016:NUTS CODE="SK"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">12139065.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">11958068.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <COMPLEMENTARY_INFO>
            <INFO_ADD>
               <P>Zákazku vyhodnocovala komisia v zložení: Ing. Viera Ďurišová, Mgr. Andrea Szaboóvá, Mgr. Katarína Rusnáková.</P>
            </INFO_ADD>
            <ADDRESS_REVIEW_BODY>
               <OFFICIALNAME>Úrad pre verejné obstarávanie</OFFICIALNAME>
               <ADDRESS>Ružová dolina 10, P.O.Box 98</ADDRESS>
               <TOWN>Bratislava</TOWN>
               <POSTAL_CODE>82005</POSTAL_CODE>
               <COUNTRY VALUE="SK"/>
               <PHONE>+421 250264176</PHONE>
               <FAX>+421 250264219</FAX>
               <URL>http://www.uvo.gov.sk</URL>
            </ADDRESS_REVIEW_BODY>
            <ADDRESS_REVIEW_INFO>
               <OFFICIALNAME>Úrad pre verejné obstarávanie</OFFICIALNAME>
               <ADDRESS>Ružová dolina 10, P.O.Box 98</ADDRESS>
               <TOWN>Bratislava</TOWN>
               <POSTAL_CODE>82005</POSTAL_CODE>
               <COUNTRY VALUE="SK"/>
               <PHONE>+421 250264176</PHONE>
               <FAX>+421 250264219</FAX>
               <URL>http://www.uvo.gov.sk</URL>
            </ADDRESS_REVIEW_INFO>
            <DATE_DISPATCH_NOTICE>2018-01-02</DATE_DISPATCH_NOTICE>
         </COMPLEMENTARY_INFO>
      </F03_2014>
   </FORM_SECTION>
</TED_EXPORT>
